TOX Regulates T Lymphocytes Differentiation and Its Function in Tumor
Overview
Authors
Affiliations
Thymocyte selection-associated high mobility group box protein (TOX) is expressed differently at all T lymphocytes development stages. Owing to more advanced scientific and technological means, including single-cell sequencing technology, heterogeneity of T lymphocytes and TOX has gradually been revealed. Further exploration of such heterogeneity will help us comprehend the developmental stage and functional characteristics of T lymphocytes in greater detail. Emerging evidence supports its regulation not only in exhausting, but also in activating T lymphocytes, thereby verifying TOX heterogeneity. TOX can be used not only as a latent intervention target for tumor diseases and chronic infections, and a therapeutic strategy for autoimmune diseases, but also as a critical factor predicting the drug response and overall survival of patients with malignant tumors.
Li Y, Li X, Han Z, Yang R, Zhou W, Peng Y Sci Rep. 2024; 14(1):28133.
PMID: 39548146 PMC: 11568293. DOI: 10.1038/s41598-024-76573-w.
Aldersey J, Lange M, Beck B, Abernathy J PLoS One. 2024; 19(9):e0309397.
PMID: 39325796 PMC: 11426453. DOI: 10.1371/journal.pone.0309397.
Exhaustion of T cells after renal transplantation.
Wang X, Zhang J, Zhong P, Wei X Front Immunol. 2024; 15:1418238.
PMID: 39165360 PMC: 11333218. DOI: 10.3389/fimmu.2024.1418238.
TOX: a potential new immune checkpoint in cancers by pancancer analysis.
Qiu S, Lin W, Zhou Z, Hong Q, Chen S, Li J Discov Oncol. 2024; 15(1):354.
PMID: 39152366 PMC: 11329495. DOI: 10.1007/s12672-024-01236-1.
Single-nuclei sequencing of uterine serous carcinoma reveals racial differences in immune signaling.
Foley K, Adli M, Kim J Proc Natl Acad Sci U S A. 2024; 121(34):e2402998121.
PMID: 39133838 PMC: 11348309. DOI: 10.1073/pnas.2402998121.